UK markets open in 1 hour 36 minutes
  • NIKKEI 225

    +184.19 (+0.67%)

    -477.26 (-2.20%)

    +0.15 (+0.20%)

    +13.50 (+0.72%)
  • DOW

    -127.89 (-0.38%)

    -598.06 (-3.07%)
  • CMC Crypto 200

    -14.56 (-2.71%)
  • ^IXIC

    -193.84 (-1.59%)
  • ^FTAS

    +36.82 (+0.86%)

Neurostimulation Devices Market Report 2023-2033


Forecasts by Product (Deep Brain Stimulator, Gastric Electric Stimulator, Spinal Cord Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Transcutaneous Electrical Nerve Stimulation (TENS), Others), by Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Faecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis.

New York, Jan. 04, 2023 (GLOBE NEWSWIRE) -- announces the release of the report "Neurostimulation Devices Market Report 2023-2033" -

The Neurostimulation Devices Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Favourable Regulatory and Reimbursement Scenario will Accelerate Neurostimulation Devices Market Growth

Presence of regulatory bodies such as MHRA and NICE for clinical and safety guidelines and enabling regulatory approval of neurostimulation devices under Class III devices will favour industry growth in the future. Growing focus of regulatory authorities in addressing the need for effective drug development for neurological disorders will accelerate business growth. For instance, Stimwave Technologies was granted the authorization to decide on the reimbursement with healthcare insurers over and above of the DRG payment limits for its chronic pain management products.

Complications Associated with Usage of Neurostimulation Devices

The complications in neurostimulation devices are majorly categorized into hardware complications, biological complications, and programming or therapy-related complications. Some of the hardware-related complications include battery depletion, flipping, lead migration, and recharging difficulties. Biological complications include the pain related to device components, wound infections, skin erosion, complications related to device removal, and accidental dural puncture. Programming related complications include loss of paranesthesia or painful paranesthesia. Complications related to programming are not very frequent, however it could result in device removal due to therapy failure. These aforementioned complications act as challenges in the adoption of neurostimulation devices, thereby restraining the growth of the market.

Lack of Skilled Healthcare Practitioners

The inadequate number of healthcare practitioners with the required skills to manage and treat neurological diseases will hamper industry growth over the coming years. Treatment and assessment are required to support diagnosis in a few cases. In most of cases, individual test results need to be interpreted carefully that requires skilled expertise. In most of the low and middle-income countries, access to healthcare services is challenging due to financial constraints, there is a shortage of skilled nurses and doctors, neurologists are rare, and neurological diagnostic services are not present. Even when neurological diseases are diagnosed, lack of patient information, and usage of traditional medicine delay the initiation of treatment.

What Questions Should You Ask before Buying a Market Research Report?

• How is the Neurostimulation Devices Market evolving?

• What is driving and restraining the Neurostimulation Devices Market?

• How will each Neurostimulation Devices submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?

• How will the market shares for each Neurostimulation Devices submarket develop from 2023 to 2033?

• What will be the main driver for the overall market from 2023 to 2033?

• Will leading Neurostimulation Devices Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?

• Who are the leading players and what are their prospects over the forecast period?

• What are the neurostimulation devices development projects for these leading companies?

• How will the industry evolve during the period between 2023 and 2033? What are the implications of neurostimulation devices development projects taking place now and over the next 10 years?

• Is there a greater need for product commercialisation to further scale the Neurostimulation Devices Market?

• Where is the Neurostimulation Devices Market heading and how can you ensure you are at the forefront of the market?

• What are the best investment options for new product and service lines?

• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Neurostimulation Devices Market today, and over the next 10 years:

• Our 250-page report provides 111 tables and 139 charts/graphs exclusively to you.

• The report highlights key lucrative areas in the industry so you can target them – NOW.

• It contains in-depth analysis of global, regional and national sales and growth.

• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Neurostimulation Devices Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.

• You will find original analyses, with business outlooks and developments.

• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising neurostimulation devices prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

By Product

• Deep Brain Stimulator

• Gastric Electric Stimulator

• Spinal Cord Stimulator

• Sacral Nerve Stimulator

• Vagus Nerve Stimulator

• Transcutaneous Electrical Nerve Stimulation

• Others

By Application

• Pain Management

• Epilepsy

• Essential Tremor

• Urinary and Fecal Incontinence

• Depression

• Dystonia

• Gastroparesis

• Parkinson’s Disease

• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

North America

• U.S.

• Canada


• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• Australia

• South Korea

• Rest of Asia Pacific

Latin America

• Brazil

• Mexico

• Rest of Latin America



• South Africa

• Rest of MEA

The report also includes profiles and for some of the leading companies in the Neurostimulation Devices Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

• Abbott Laboratories

• Advanced Bionics AG (Sonova)

• Boston Scientific Corporation

• BrainCo, Inc

• Cochlear Limited

• ElectroCore Inc.

• Helbling Holding AG

• Innovative Health Solutions, Inc.

• LivaNova PLC

• Medtronic

• MicroTransponder

• Neuronetics, Inc.

• Nihon Kohden Corporation

• Natus medical Incorporated

• Parasym Ltd.

• Synapse Biomedical Inc

• tVNS Technologies GmbH (Cerbomed)

Overall world revenue for Neurostimulation Devices Market, 2023 to 2033 in terms of value the market will surpass US$9,000 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Neurostimulation Devices Market, 2023 to 2033 report help you?

In summary, our 250-page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Neurostimulation Devices Market, 2023 to 2033 Market, with forecasts for Type of Product, Type of Application, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Neurostimulation Devices Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles of the major companies involved in the Neurostimulation Devices Market, 2023 to 2033.

Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001